2023-24 Annual report
2023-24 Executive team
April 1, 2023 – March 31, 2024
Dr. Craig Earle
Chief Executive Officer
Erika Nicholson
Vice President, Cancer Systems and Innovation
Andrea Reed
Vice President, Strategic Partnerships
Shelley Tapp
Vice President, Finance and Corporate Services (joined January 2024)
David Lynch
Vice President, Finance and Corporate Services (retired December 2023)
Rami Rahal
Vice President, Cancer Systems, Performance and Innovation (resigned June 2023)